🔗 Permalink

Inventor profile of:

Randy Lee Webb

City:

Flemington, New Jersey

Country:

United States

Published Applications:

Last publication date:

2013-08-01

Top Assignees for applications by Randy Lee Webb

The entities that hold a legal rights for patent applications filed by inventor Webb Randy Lee:

NOVARTIS AG 10 Basel, Switzerland
NOVARTIS PHARMACEUTICALS CORPORATION 1 EAST HANOVER, NJ United States

Recent patent applications by Webb Randy Lee

Randy Lee Webb from Flemington, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2013-08-01

US20130196977A1

Human necessities

USE OF ORGANIC COMPOUNDS

#2 | 2013-06-20

US20130158086A1

Human necessities

Methods of treatment and pharmaceutical composition

#3 | 2013-06-20

US20130158085A1

Human necessities

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITION

#4 | 2012-06-07

US20120142638A1

Human necessities

COMBINATION OF ORGANIC COMPOUNDS

#5 | 2012-06-07

US20120138506A1

Human necessities

Methods of treatment and pharmaceutical composition

#6 | 2012-05-10

US20120115854A1

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING ANTIHYPERTENSIVE AGENTS

#7 | 2012-05-01

US10416039

Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension

#8 | 2012-03-22

US20120071470A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING A RENIN INHIBITOR, A CALCIUM CHANNEL BLOCKER AND A DIURETIC

#9 | 2012-01-19

US20120016035A1

Human necessities

Synergistic combinations comprising a renin inhibitor for cardiovascular diseases

#10 | 2012-01-12

US20120010295A1

Human necessities

Synergistic combinations comprising a renin inhibitor for cardiovascular diseases

#11 | 2012-01-05

US20120004312A1

Human necessities

Synergistic combinations comprising a renin inhibitor for cardiovascular diseases

#12 | 2010-08-05

US20100196467A1

Human necessities

THERAPEUTIC COMBINATION OF AMLODIPINE AND BENAZEPRIL/BENAZEPRILAT

#13 | 2010-02-25

US20100048654A1

Human necessities

USE OF VALSARTAN OR ITS METABOLITE TO IN HIBIT PLATELET AGGREGATION

#14 | 2009-10-01

US20090247582A1

Human necessities

METHODS OF TREATING ATHEROSCLEROSIS

#15 | 2009-04-16

US20090099241A1

Human necessities

Pharmaceutical composition containing anti-hypertensive agents

#16 | 2009-01-01

US20090005361A1

Human necessities

Combination of Organic Compounds

#17 | 2008-12-23

US10341868

Methods of treatment and pharmaceutical composition

#18 | 2008-12-04

US20080300238A1

Human necessities

Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic

#19 | 2008-10-23

US20080262059A1

Human necessities

Methods of treatment and pharmaceutical composition

#20 | 2008-10-23

US20080261958A1

Human necessities

Combination of Organic Compounds

#21 | 2008-10-16

US20080255084A1

Human necessities

Combination of Organic Compounds

#22 | 2008-05-22

US20080119557A1

Human necessities

Combination Of Organic Compounds

#23 | 2008-04-10

US20080085914A1

Human necessities

Use Of Organic Compounds

#24 | 2007-04-26

US20070093431A1

Human necessities

COMBINATION OF ORGANIC COMPOUNDS

#25 | 2005-10-06

US20050222137A1

Human necessities

Combination of organic compounds

#26 | 2005-09-08

US20050197372A1

Human necessities

Use of valsartan or its metabolite to inhibit platelet aggregation

#27 | 2005-08-18

US20050182042A1

Human necessities

Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic

#28 | 2005-05-12

US20050101638A1

Human necessities

Combination of organic compounds

InventorID:

301308 ⎘